Skip to main content
. 2016 Mar;101(3):346–355. doi: 10.3324/haematol.2015.135780

Figure 1.

Figure 1.

Graphical overview of dosing of nelfinavir (dose levels DL0, DL1, DL2) and bortezomib together with the time points at which samples for pharmakokinetic/pharmakodynamic (PK/PD) analysis were collected (PK1-5). Nelfinavir dosing in week -1 was only performed in cycle 1.